Linked Data Explorerhttp://worldcat.org/entity/work/id/1411314116
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012
Open All Close All
http://schema.org/about
- http://id.worldcat.org/fast/1204155
- http://id.loc.gov/authorities/subjects/sh90002675
- http://id.loc.gov/authorities/subjects/sh85047672
- http://id.loc.gov/authorities/names/n80126147
- http://id.loc.gov/authorities/subjects/sh89000501
- http://id.worldcat.org/fast/898661
- http://viaf.org/viaf/151271988
- http://id.worldcat.org/fast/549734
- http://id.loc.gov/authorities/subjects/sh2009008270
- http://id.loc.gov/authorities/subjects/sh2009123884
- http://id.worldcat.org/fast/922527
- http://id.worldcat.org/fast/1749120
- http://id.worldcat.org/fast/939971
- http://viaf.org/viaf/122482876
http://schema.org/genre
- "Rules"@en
http://schema.org/name
- "Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012"@en